APA (7th ed.) Citation

Y, H., NP, D., S, S., AK, S., C, L., D, G., . . . DJ, R. (2026). Preclinical efficacy and safety assessment of engineered regulatory T cells for treatment of IPEX and other autoimmune disorders. Molecular therapy : the journal of the American Society of Gene Therapy, 34(7), 4035. https://doi.org/10.1016/j.ymthe.2026.03.017

Chicago Style (17th ed.) Citation

Y, Honaker, et al. "Preclinical Efficacy and Safety Assessment of Engineered Regulatory T Cells for Treatment of IPEX and Other Autoimmune Disorders." Molecular Therapy : The Journal of the American Society of Gene Therapy 34, no. 7 (2026): 4035. https://doi.org/10.1016/j.ymthe.2026.03.017.

MLA (9th ed.) Citation

Y, Honaker, et al. "Preclinical Efficacy and Safety Assessment of Engineered Regulatory T Cells for Treatment of IPEX and Other Autoimmune Disorders." Molecular Therapy : The Journal of the American Society of Gene Therapy, vol. 34, no. 7, 2026, p. 4035, https://doi.org/10.1016/j.ymthe.2026.03.017.